Risk categorization of AML based on karyotyping of leukemic blasts has become routine. Mutations in NPM1, CCAAT enhancer-binding protein-α (with double-mutations) and FCT3-internal tandem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback